This is the analyst who has gold bugs thinking $12,000 is not only possible, it's the right price
Myrmikan Capital's Daniel Oliver says we're in the first phase of a massive bull market and the second could come fast.
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
The market seems mostly unfazed by the latest flare-up in the Middle East. Here's what investors need to know.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse ArticlesMyrmikan Capital's Daniel Oliver says we're in the first phase of a massive bull market and the second could come fast.
Alphabet is a leader in search and cloud computing, with nice advantages in each.
Dutch Bros Inc. (NYSE: BROS) ("Dutch Bros"), one of the fastest-growing quick service beverage brands in the U.S., is bringing the flavors customers love t...
BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish fourth quarter and full year 202...
AI in oncology is poised to revolutionize cancer care through early, accurate detection, and personalized treatment, driven by rising cancer rates. Key opp...
The changes come as the wider retail-pharmacy market has been upended in recent years.
A dollar-cost averaging (DCA) strategy makes sense for Bitcoin right now.
Bitcoin was little changed Tuesday, while ether fell. CoinDesk's memecoin Index rose.
Alphabet's bond issuance in the U.S. on Monday saw intense demand and was more than five times oversubscribed. The appeal of one hundred-year bonds, though...
Public companies that amassed large Solana positions in 2025 have paused accumulation as equity markets reprice SOL-heavy balance sheets.
Target is cutting around 500 jobs, as it tries to put money into making its stores more appealing places to shop, according to reports.
The pharmaceutical giant announced profit in line with expectations and revenue that slightly beat forecasts on Tuesday.